Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer

Annals of Surgical Oncology

Volumn 11, Issue 11, 2004, Pages 1018-1024

  Rietman, J S ^a,b,c   Dijkstra, P U ^b,c   Geertzen, J H B ^b,c   Baas, P ^a   De Vries, J ^b   Dolsma, W V ^b   Groothoff, J W ^c   Eisma, W H ^b   Hoekstra, H J ^b  

^a MARTINI HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Axillary dissection; Breast cancer; Morbidity; Radiation; Sentinel lymph node; Staging

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARM MOVEMENT; ARM MUSCLE; ARTICLE; AXILLA; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISABILITY; FOREARM; GRIP STRENGTH; HORMONAL THERAPY; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUSCLE STRENGTH; PARTIAL MASTECTOMY; PREDICTION; SENTINEL LYMPH NODE BIOPSY; SHOULDER; STATISTICAL SIGNIFICANCE; ARM; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; DISABLED PERSON; EDEMA; FEMALE; HAND GRIP; LYMPHADENECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROSPECTIVE STUDY;

ACTIVITIES OF DAILY LIVING; ARM; AXILLA; BREAST NEOPLASMS; DISABLED PERSONS; EDEMA; FEMALE; HAND STRENGTH; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; MORBIDITY; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROSPECTIVE STUDIES; RANGE OF MOTION, ARTICULAR; SENTINEL LYMPH NODE BIOPSY;

EID: 16644382369     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.03.512     Document Type: Article

References (52)

1. Moffat FL, Senofsky GM, Davis K, et al. Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 1992;51:8-13.
2. Donegan WL. Prognostic factors: stage and receptor status in breast cancer. Cancer 1992;70:1755-64.
3. Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983;52:1551-7.
4. Carter CL, Allen C, Henson DE. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
5. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer 1995;76:1491-512.
6. Thomson AM, Air M, Jack WJL, Kerr GR, Rodger A, Chetty U. Arm morbidity after breast conservation and axillary therapy. Breast 1995;4:273-6.
7. Liljegren G, Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Eur J Cancer 1997;33:193-9.
8. Pezner RD, Patterson MP, Hill RL, et al. Arm lymphoedema in patients treated conservatively for breast cancer: relationship to patients age and axillary node dissection techniques. Int J Radiat Oncol Biol Phys 1986;12:2079-83.
9. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-8.
10. Warmuth MA, Bowen G, Pronitz LR, et al. Complications of axillary lymph node dissection for carcinoma of the breast. Cancer 1998;83:1362-8.
11. Kuehn T, Klauss W, Darsow M, et al. Long-term morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 2000;64:275-86.
12. Rietman JS, Dijkstra PU, Hoekstra HJ, et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 2003;29:229-38.
13. Tobin MB, Lacey HJ, Meyer L, Mortimer PS. The psychological morbidity of breast cancer-related arm swelling. Cancer 1993;72:3248-53.
14. Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999;17:143-9.
15. Ververs JMMA, Roumen RMH, Vingerhoets AJJM, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001;37:991-9.
16. Poole K, Fallowfield LJ. The psychological impact of post-operative arm morbidity following axillary surgery for breast cancer: a critical review. Breast 2002;11:81-7.
17. Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002;20:4242-8.
18. Rietman JS, Dijkstra PU, Debreczeni R, Geertzen JHB, Robinson DPH, De Vries J. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil 2004;26:78-84.
19. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-9.
20. Statman RC, Jones RC, Cabot MC, et al. Sentinal lymphadenectomy. A technique to eliminate axillary dissection in node-negative breast cancer (abstract). Proc Am Soc Clin Oncol 1996;15:167A.
21. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
22. Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 2001;92:748-52.
23. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53.
24. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560-6.
25. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000;88:608-14.
26. Haid A, Köberle-Wührer R, Knauer M, et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2002;73:31-6.
27. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002;183:23-7.
28. Baron RH, Fey JV, Raboy S, et al. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum 2002;29:652-9.
29. Temple LKF, Baron R, Cody HS, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 2002;9:654-62.
30. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002;9:745-53.
31. Haid A, Kuehn P, Konstantiniuk R, et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 2002;28:705-10.
32. Leidenius M, Leppänen, Krogerus L, von Smitten K. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 2003;185:127-30.
33. Schijven MP, Vingerhoets AJJM, Rutten HJT, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003;29:341-50.
34. Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003;89:648-52.
35. Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003;138:482-8.
36. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 2001;77:165-70.
37. International Union Against Cancer. Breast tumours. In: Sobin LH, Wittekind Ch, eds. TNM: Classification of Malignant Tumours. 6th ed. New York: Wiley-Liss, 2002:131-42.
38. Rutgers EJ, Jansen L, Nieweg OE, de Vries J, Schraffordt Koops H, Kroon BB. Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol 1998;24:316-9.
39. Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 1992;50:47-52.
40. Gerber L, Lampert M, Wood C, et al. Comparison of pain, motion and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation. Breast Cancer Res Treat 1992;21:139-45.
41. Green S, Buchbinder R, Forbes A, Bellamy N. A standardised protocol for measurement of range of movement of the shoulder using the Plurimeter-V inclinometer and assessment of its intrarater and interrater reliability. Arthritis Care Res 1998;11:43-52.
42. van der Ploeg RJO. Hand-Held Dynamometry (Thesis). Groningen, The Netherlands: University of Groningen, 1992.
43. van der Ploeg RJO, Fidler V, Oosterhuis HJGH. Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry 1991;54:244-7.
44. Balogun JA, Powell R, Trullender B, Olson S, Balogun AO. Intra-and inter-tester reliability of the Nicholas® hand-held dynamometer during evaluation of upper extremity isometric muscle strength. Eur J Phys Med Rehabil 1998;8:48-53.
45. Swedborg I, Borg G, Sarnelid M. Somatic sensation and discomfort in the arm of post-mastectomy patients. Scand J Rehabil Med 1981:13:23-9.
46. Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg 1984;9:222-6.
47. van der Heijden GJMG. Shoulder Disorder Treatment: Efficacy of Ultrasound Therapy and Electrotherapy (Thesis). Maastricht, The Netherlands: University of Maastricht, 1996.
48. van der Heijden GJ, Leffers P, Bouter LM. Shoulder disability questionnaire design and responsiveness of a functional status measure. J Clin Epidemiol 2000;53:29-38.
49. Kempen GI, Miedema I, Ormel J, Molenaar W. The assessment of disability with the Groningen Activity Restriction Scale. Conceptual framework and psychometric properties. Soc Sci Med 1996;43:1601-10.
50. Suurmeijer TPBM, Doeglas DM, Moum T, et al. The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health 1994;84:170-3.
51. Bentzen SM, Overgaard M, Thames HD. Fractionating sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys 1989;17:531-7.
52. Sugden EM, Rezvani M, Harrison JM, Hughes LK. Shoulder movement after the treatment of early stage breast cancer. Clin Oncol (R Coll Radiol) 1998;10:173-81.